Status:
UNKNOWN
Effectiveness of a Schema Therapy on Anxiety in Patients With Multiple Sclerosis
Lead Sponsor:
Paris Nanterre University
Collaborating Sponsors:
Isfahan University of Medical Sciences
Conditions:
Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
It is a multicentric randomized and controlled study comparing a Scheme therapy program versus local practice in RRMS patients with anxiety. Patients will assist to twenty once-weekly group sessions w...
Detailed Description
A parallel arm randomized controlled trial comparing a group receiving Scheme Therapy plus current usual practice versus a group receiving current local practice only. The trial will take place in KAS...
Eligibility Criteria
Inclusion
- subject has relapsing remitting MS
- anxiety (score \>26 at the BAI scale)
- history of psychotic disorders
- history of cognitive deficiency
- use anti-depressant in the past 3 months
- history of relapse in the past 3 month
- expanded Disability Status Scale score less than 6
- ability reading and writing Persian
- Non hospitalized
Exclusion
- history of psychotic disorders
- history of cognitive deficiency
- use anti-depressant in the past 3 months
- history of relapse in the past 3 month
Key Trial Info
Start Date :
December 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2019
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT04030819
Start Date
December 20 2018
End Date
December 15 2019
Last Update
July 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
university Paris Nanterre
Paris, France, 75